LifePoint Health, Inc. (NASDAQ:LPNT) issued its earnings results on Tuesday, August 1st. The company reported $0.96 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.06, Morningstar.com reports. The company had revenue of $1.59 billion during the quarter, compared to analysts’ expectations of $1.64 billion. LifePoint Health had a return on equity of 7.40% and a net margin of 2.61%. LifePoint Health’s quarterly revenue was up .2% compared to the same quarter last year. During the same period in the prior year, the business posted $0.69 EPS. LifePoint Health updated its FY17 guidance to $3.92-$4.20 EPS.
LifePoint Health (NASDAQ LPNT) opened at 57.45 on Friday. The stock has a 50 day moving average price of $61.96 and a 200 day moving average price of $62.71. The company has a market cap of $2.30 billion, a price-to-earnings ratio of 12.86 and a beta of 0.86. LifePoint Health has a 12 month low of $50.60 and a 12 month high of $70.95.
In other news, Chairman William F. Carpenter III sold 82,347 shares of the company’s stock in a transaction on Thursday, June 15th. The stock was sold at an average price of $64.15, for a total transaction of $5,282,560.05. Following the transaction, the chairman now directly owns 504,535 shares of the company’s stock, valued at $32,365,920.25. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Chairman William F. Carpenter III sold 17,653 shares of the company’s stock in a transaction on Monday, July 17th. The stock was sold at an average price of $65.06, for a total value of $1,148,504.18. Following the transaction, the chairman now directly owns 439,841 shares in the company, valued at $28,616,055.46. The disclosure for this sale can be found here. Insiders own 7.28% of the company’s stock.
Several research firms have weighed in on LPNT. Leerink Swann upgraded LifePoint Health from a “market perform” rating to an “outperform” rating and increased their price objective for the stock from $73.00 to $74.00 in a report on Tuesday, June 6th. BidaskClub cut LifePoint Health from a “buy” rating to a “hold” rating in a report on Saturday, July 8th. Royal Bank Of Canada reiterated a “buy” rating and issued a $77.00 price objective on shares of LifePoint Health in a report on Wednesday, July 5th. Zacks Investment Research upgraded LifePoint Health from a “hold” rating to a “buy” rating and set a $75.00 price objective for the company in a report on Tuesday, July 4th. Finally, TheStreet cut LifePoint Health from a “b-” rating to a “c+” rating in a report on Wednesday. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating and six have given a buy rating to the stock. LifePoint Health has a consensus rating of “Hold” and an average target price of $66.18.
LifePoint Health Company Profile
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
What are top analysts saying about LifePoint Health Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for LifePoint Health Inc. and related companies.